|
|
News Breaks
|
October 27, 2009
|
| 08:13 EDT |  | HLCS |
| theflyonthewall.com: | Helicos BioSciences announces Q3 highlights | | Helicos BioSciences Corp. announced its operational, technical and scientific highlights for the quarter ended September 30, 2009. Highlights included RIKEN Yokohama Institute Omics Science Center agreed to purchase four Systems and entered into a significant reagent supply contract; Correlagen purchased a System for novel, high-content, genetic tests based on resequencing broad panels of genes involved in disease areas such as cardiology, endocrinology, neuropsychiatry, and immunology; Helicos’s placement installations at Dana-Farber Cancer Institute, Mass General Hospital Cancer Center and Ontario Institute for Cancer Research continue to produce meaningful scientific results; Helicos’s commercial activity continues to be enhanced by the new funding opportunities from the National Institutes of Health and the National Science Foundation, released as part of the American Recovery and Reinvestment Act; Helicos scientists have received a two year grant, totaling $2.9M, as part of the Sequencing Technology Development Program representing NHGRI’s Signature Project for the American Recovery and Reinvestment Act. :theflyonthewall.com |
|
|
News For HLCS From The Last 14 Days Check below for free stories on HLCS the last two weeks.
| Sign up for a free trial to see the rest of the stories you've been missing. |
There are no results for these search parameters.
|
|
|
|
